Emergency Department Discharge of Pulmonary Embolus Patients

Benefit of early discharge among patients with low-risk pulmonary embolism

(2017) Li Wang et al.   PLoS One

Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design

(2016) Adam J. Singer et al.   ACADEMIC EMERGENCY MEDICINE

Antithrombotic Therapy for VTE Disease

(2016) Clive Kearon et al.   CHEST

Immediate Discharge and Home Treatment With Rivaroxaban of Low-risk Venous Thromboembolism Diagnosed in Two U.S. Emergency Departments: A One-year Preplanned Analysis

(2015) Daren M. Beam et al.   ACADEMIC EMERGENCY MEDICINE

Daily Hospitalization Costs in Patients with Deep Vein Thrombosis or Pulmonary Embolism Treated with Anticoagulant Therapy

(2015) Joseph F. Dasta et al.   THROMBOSIS RESEARCH

Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function

(2013) W. Zondag et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Hestia criteria can discriminate high- from low-risk patients with pulmonary embolism

(2012) Wendy Zondag et al.   EUROPEAN RESPIRATORY JOURNAL

Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial

(2011) Drahomir Aujesky et al.   LANCET

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral Rivaroxaban for Symptomatic Venous Thromboembolism

(2010)   NEW ENGLAND JOURNAL OF MEDICINE